Drake, M. J., MacDiarmid, S., Chapple, C. R., Esen, A., Athanasiou, S., Cambronero Santos, J., . . . Stoelzel, M. (2017). Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE). Int J Clin Pract.
শিকাগো স্টাইলে সাইটেশনDrake, Marcus J., et al. "Cardiovascular Safety in Refractory Incontinent Patients With Overactive Bladder Receiving Add‐on Mirabegron Therapy to Solifenacin (BESIDE)." Int J Clin Pract 2017.
এমএলএ সাইটেশনDrake, Marcus J., et al. "Cardiovascular Safety in Refractory Incontinent Patients With Overactive Bladder Receiving Add‐on Mirabegron Therapy to Solifenacin (BESIDE)." Int J Clin Pract 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.